Long non-coding RNAs: Critical players in hepatocellular carcinoma

International Journal of Molecular Sciences

Volumn 15, Issue 11, 2014, Pages 20434-20448

  Sun, Jin ^a   Bie, Beibei ^a   Zhang, Shu ^a   Yang, Jun ^a   Li, Zongfang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Biological roles; Dysregulation; Hepatocellular carcinoma; Long noncoding RNA; Molecular mechanism

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HISTONE LYSINE METHYLTRANSFERASE; LONG UNTRANSLATED RNA; MITOGEN ACTIVATED PROTEIN KINASE; ORPHAN NUCLEAR RECEPTOR; POLYCOMB GROUP PROTEIN; POTASSIUM CHANNEL KCNQ; RNA H19; RNA POLYMERASE II; TRANSCRIPTION FACTOR EZH2;

APOPTOSIS; CANCER GROWTH; CARCINOGENESIS; DOWN REGULATION; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LIVER CELL CARCINOMA; METASTASIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MICROARRAY; REVIEW; SHORT TANDEM REPEAT; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER TUMOR; METABOLISM; PATHOLOGY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER NEOPLASMS; RNA, LONG NONCODING;

EID: 84910129785     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151120434     Document Type: Review

References (70)

1. Forner, A.; Llovet, J.M.; Bruix, J. Hepatocellular carcinoma. Lancet 2012, 379, 1245-1255.
2. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA: A Cancer J. Clin. 2011, 61, 69-90.
3. Villanueva, A.; Minguez, B.; Forner, A.; Reig, M.; Llovet, J.M. Hepatocellular carcinoma: Novel molecular approaches for diagnosis, prognosis, and therapy. Ann. Rev. Med. 2010, 61, 317-328.
4. Aravalli, R.N.; Steer, C.J.; Cressman, E.N. Molecular mechanisms of hepatocellular carcinoma. Hepatology 2008, 48, 2047-2063.
5. Mah, W.C.; Lee, C.G. DNA methylation: Potential biomarker in hepatocellular carcinoma. Biomark. Res. 2014, 2, 5.
6. Kumar, M.; Zhao, X.; Wang, X.W. Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: One step closer to personalized medicine? Cell Biosci. 2011, 1, 5.
7. Gramantieri, L.; Fornari, F.; Callegari, E.; Sabbioni, S.; Lanza, G.; Croce, C.M.; Bolondi, L.; Negrini, M. MicroRNA involvement in hepatocellular carcinoma. J. Cell. Mol. Med. 2008, 12, 2189-2204.
8. Saito, Y.; Hibino, S.; Saito, H. Alterations of epigenetics and microRNA in hepatocellular carcinoma. Hepatol. Res. 2014, 44, 31-42.
9. Chervona, Y.; Costa, M. Histone modifications and cancer: Biomarkers of prognosis? Am. J. Cancer Res. 2012, 2, 589-597.
10. Ma, L.; Chua, M.S.; Andrisani, O.; So, S. Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives. World J. Gastroenterol. 2014, 20, 333-345.
11. Carninci, P.; Kasukawa, T.; Katayama, S.; Gough, J.; Frith, M.C.; Maeda, N.; Oyama, R.; Ravasi, T.; Lenhard, B.; Wells, C., et al. The transcriptional landscape of the mammalian genome. Science 2005, 309, 1559-1563.
12. Kapranov, P.; Cheng, J.; Dike, S.; Nix, D.A.; Duttagupta, R.; Willingham, A.T.; Stadler, P.F.; Hertel, J.; Hackermuller, J.; Hofacker, I.L., et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007, 316, 1484-1488.
13. Van Heesch, S.; van Iterson, M.; Jacobi, J.; Boymans, S.; Essers, P.B.; de Bruijn, E.; Hao, W.; Macinnes, A.W.; Cuppen, E.; Simonis, M. Extensive localization of long noncoding RNAs to the cytosol and mono-and polyribosomal complexes. Genome Biol. 2014, 15, R6.
14. Sun, J.; Lin, Y.; Wu, J. Long non-coding RNA expression profiling of mouse testis during postnatal development. PLoS One 2013, 8, e75750.
15. Wapinski, O.; Chang, H.Y. Long noncoding RNAs and human disease. Trends Cell Biol. 2011, 21, 354-361.
16. Li, C.H.; Chen, Y. Targeting long non-coding RNAs in cancers: Progress and prospects. Int. J. Biochem. Cell Biol. 2013, 45, 1895-1910.
17. Gutschner, T.; Diederichs, S. The hallmarks of cancer: A long non-coding RNA point of view. RNA Biol. 2012, 9, 703-719.
18. Kallen, A.N.; Zhou, X.B.; Xu, J.; Qiao, C.; Ma, J.; Yan, L.; Lu, L.; Liu, C.; Yi, J.S.; Zhang, H., et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol. Cell 2013, 52, 101-112.
19. Tsang, W.P.; Ng, E.K.; Ng, S.S.; Jin, H.; Yu, J.; Sung, J.J.; Kwok, T.T. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 2010, 31, 350-358.
20. Shi, Y.; Wang, Y.; Luan, W.; Wang, P.; Tao, T.; Zhang, J.; Qian, J.; Liu, N.; You, Y. Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS One 2014, 9, e86295.
21. Luo, M.; Li, Z.; Wang, W.; Zeng, Y.; Liu, Z.; Qiu, J. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett. 2013, 333, 213-221.
22. Kim, K.S.; Lee, Y.I. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Cancer Lett. 1997, 119, 143-148.
23. Iizuka, N.; Oka, M.; Yamada-Okabe, H.; Mori, N.; Tamesa, T.; Okada, T.; Takemoto, N.; Tangoku, A.; Hamada, K.; Nakayama, H. Comparison of gene expression profiles between hepatitis B virus-and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res. 2002, 62, 3939-3944.
24. Matouk, I.J.; DeGroot, N.; Mezan, S.; Ayesh, S.; Abu-lail, R.; Hochberg, A.; Galun, E. The H19 non-coding RNA is essential for human tumor growth. PLoS One 2007, 2, e845.
25. Matouk, I.J.; Mezan, S.; Mizrahi, A.; Ohana, P.; Abu-Lail, R.; Fellig, Y.; Degroot, N.; Galun, E.; Hochberg, A. The oncofetal H19 RNA connection: Hypoxia, p53 and cancer. Biochim. Biophys. Acta 2010, 1803, 443-451.
26. Zhang, J.; Zhang, P.; Wang, L.; Piao, H.L.; Ma, L. Long non-coding RNA HOTAIR in carcinogenesis and metastasis. Acta Biochim. Biophys. Sin. 2014, 46, 1-5.
27. Geng, Y.; Xie, S.; Li, Q.; Ma, J.; Wang, G. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J. Int. Med. Res. 2011, 39, 2119-2128.
28. Ishibashi, M.; Kogo, R.; Shibata, K.; Sawada, G.; Takahashi, Y.; Kurashige, J.; Akiyoshi, S.; Sasaki, S.; Iwaya, T.; Sudo, T., et al. Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol. Rep. 2013, 29, 946-950.
29. Wang, K.C.; Yang, Y.W.; Liu, B.; Sanyal, A.; Corces-Zimmerman, R.; Chen, Y.; Lajoie, B.R.; Protacio, A.; Flynn, R.A.; Gupta, R.A., et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 2011, 472, 120-124.
30. Quagliata, L.; Matter, M.S.; Piscuoglio, S.; Arabi, L.; Ruiz, C.; Procino, A.; Kovac, M.; Moretti, F.; Makowska, Z.; Boldanova, T. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology 2014, 59, 911-923.
31. Panzitt, K.; Tschernatsch, M.M.; Guelly, C.; Moustafa, T.; Stradner, M.; Strohmaier, H.M.; Buck, C.R.; Denk, H.; Schroeder, R.; Trauner, M. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007, 132, 330-342.
32. Wang, J.; Liu, X.; Wu, H.; Ni, P.; Gu, Z.; Qiao, Y.; Chen, N.; Sun, F.; Fan, Q. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010, 38, 5366-5383.
33. Du, Y.; Kong, G.; You, X.; Zhang, S.; Zhang, T.; Gao, Y.; Ye, L.; Zhang, X. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J. Biol. Chem. 2012, 287, 26302-26311.
34. Wan, J.; Huang, M.; Zhao, H.; Wang, C.; Zhao, X.; Jiang, X.; Bian, S.; He, Y.; Gao, Y. A novel tetranucleotide repeat polymorphism within KCNQ1OT1 confers risk for hepatocellular carcinoma. DNA Cell Biol. 2013, 32, 628-634.
35. Loewer, S.; Cabili, M.N.; Guttman, M.; Loh, Y.H.; Thomas, K.; Park, I.H.; Garber, M.; Curran, M.; Onder, T.; Agarwal, S., et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat. Genet. 2010, 42, 1113-1117.
36. Wang, Y.; Xu, Z.; Jiang, J.; Xu, C.; Kang, J.; Xiao, L.; Wu, M.; Xiong, J.; Guo, X.; Liu, H. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev. Cell 2013, 25, 69-80.
37. Takahashi, K.; Yan, I.K.; Haga, H.; Patel, T. Modulation of hypoxia-signaling pathways by extracellular long non-coding RNA regulator of reprogramming. J. Cell Sci. 2014, 127, 1585-1594.
38. Lin, R.; Maeda, S.; Liu, C.; Karin, M.; Edgington, T. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007, 26, 851-858.
39. Lai, M.C.; Yang, Z.; Zhou, L.; Zhu, Q.Q.; Xie, H.Y.; Zhang, F.; Wu, L.M.; Chen, L.M.; Zheng, S.S. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med. Oncol. 2012, 29, 1810-1816.
40. Benetatos, L.; Vartholomatos, G.; Hatzimichael, E. MEG3 imprinted gene contribution in tumorigenesis. Int. J. Cancer 2011, 129, 773-779.
41. Huang, J.; Zhang, X.; Zhang, M.; Zhu, J.-D.; Zhang, Y.-L.; Lin, Y.; Wang, K.-S.; Qi, X.-F.; Zhang, Q.; Liu, G.-Z. Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma. Carcinogenesis 2007, 28, 1094-1103.
42. Braconi, C.; Kogure, T.; Valeri, N.; Huang, N.; Nuovo, G.; Costinean, S.; Negrini, M.; Miotto, E.; Croce, C.; Patel, T. MicroRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011, 30, 4750-4756.
43. Yuan, S.X.; Tao, Q.F.; Wang, J.; Yang, F.; Liu, L.; Wang, L.L.; Zhang, J.; Yang, Y.; Liu, H.; Wang, F., et al. Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma. Cancer Lett. 2014, 349, 87-94.
44. Huang, J.F.; Guo, Y.J.; Zhao, C.X.; Yuan, S.X.; Wang, Y.; Tang, G.N.; Zhou, W.P.; Sun, S.H. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology 2013, 57, 1882-1892.
45. Yang, F.; Zhang, L.; Huo, X.S.; Yuan, J.H.; Xu, D.; Yuan, S.X.; Zhu, N.; Zhou, W.P.; Yang, G.S.; Wang, Y.Z. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011, 54, 1679-1689.
46. Yuan, S.X.; Yang, F.; Yang, Y.; Tao, Q.F.; Zhang, J.; Huang, G.; Yang, Y.; Wang, R.Y.; Yang, S.; Huo, X.S., et al. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients’ poor recurrence-free survival after hepatectomy. Hepatology 2012, 56, 2231-2241.
47. Yang, F.; Huo, X.S.; Yuan, S.X.; Zhang, L.; Zhou, W.P.; Wang, F.; Sun, S.H. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol. Cell 2013, 49, 1083-1096.
48. Yuan, J.H.; Yang, F.; Wang, F.; Ma, J.Z.; Guo, Y.J.; Tao, Q.F.; Liu, F.; Pan, W.; Wang, T.T.; Zhou, C.C., et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 2014, 25, 666-681.
49. Wang, F.; Yuan, J.H.; Wang, S.H.; Yang, F.; Yuan, S.X.; Ye, C.; Yang, N.; Zhou, W.P.; Li, W.L.; Li, W., et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology 2014, 60, 1278-1290.
50. Yang, H.; Zhong, Y.; Xie, H.; Lai, X.; Xu, M.; Nie, Y.; Liu, S.; Wan, Y.J. Induction of the liver cancer-down-regulated long noncoding RNA uc002mbe.2 mediates trichostatin-induced apoptosis of liver cancer cells. Biochem. Pharmacol. 2013, 85, 1761-1769.
51. Xu, W.-H.; Zhang, J.-B.; Dang, Z.; Li, X.; Zhou, T.; Liu, J.; Wang, D.-S.; Song, W.-J.; Dou, K.-F. Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma. Int. J. Biol. Sci. 2014, 10, 664.
52. Liu, X.-H.; Sun, M.; Nie, F.-Q.; Ge, Y.-B.; Zhang, E.-B.; Yin, D.-D.; Kong, R.; Xia, R.; Lu, K.-H.; Li, J.-H. LncRNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol. Cancer 2014, 13, 92.
53. Tsai, M.C.; Manor, O.; Wan, Y.; Mosammaparast, N.; Wang, J.K.; Lan, F.; Shi, Y.; Segal, E.; Chang, H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329, 689-693.
54. Pandey, R.R.; Mondal, T.; Mohammad, F.; Enroth, S.; Redrup, L.; Komorowski, J.; Nagano, T.; Mancini-DiNardo, D.; Kanduri, C. KCNQ1OT1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell 2008, 32, 232-246.
55. Leucci, E.; Patella, F.; Waage, J.; Holmstrom, K.; Lindow, M.; Porse, B.; Kauppinen, S.; Lund, A.H. MicroRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci. Rep. 2013, 3, 2535.
56. Han, Y.; Liu, Y.; Zhang, H.; Wang, T.; Diao, R.; Jiang, Z.; Gui, Y.; Cai, Z. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1. FEBS Lett. 2013, 587, 3875-3882.
57. Kaneko, S.; Bonasio, R.; Saldana-Meyer, R.; Yoshida, T.; Son, J.; Nishino, K.; Umezawa, A.; Reinberg, D. Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin. Mol. Cell 2014, 53, 290-300.
58. Budhu, A.; Forgues, M.; Ye, Q.H.; Jia, H.L.; He, P.; Zanetti, K.A.; Kammula, U.S.; Chen, Y.; Qin, L.X.; Tang, Z.Y., et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 2006, 10, 99-111.
59. Rinn, J.L.; Chang, H.Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 2012, 81, 145-166.
60. Denzler, R.; Agarwal, V.; Stefano, J.; Bartel, D.P.; Stoffel, M. Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol. Cell 2014, 54, 766-776.
61. Geisler, S.; Coller, J. RNA in unexpected places: Long non-coding RNA functions in diverse cellular contexts. Nat. Rev. Mol. Cell. Biol. 2013, 14, 699-712.
62. Kutter, C.; Watt, S.; Stefflova, K.; Wilson, M.D.; Goncalves, A.; Ponting, C.P.; Odom, D.T.; Marques, A.C. Rapid turnover of long noncoding RNAs and the evolution of gene expression. PLoS Genet. 2012, 8, e1002841.
63. Xie, H.; Ma, H.W.; Zhou, D.Q. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed. Res. Int. 2013, 2013, 136106.
64. Lee, B.Y.; Mazar, J.; Aftab, M.N.; Qi, F.; Shelley, J.; Li, J.L.; Govindarajan, S.; Valerio, F.; Rivera, I.; Thurn, T., et al. Long noncoding RNAs as putative biomarkers for prostate cancer detection. J. Mol. Diagn. 2014, 16, 615-626.
65. Huang, Y.S.; Hsieh, H.Y.; Shih, H.M.; Sytwu, H.K.; Wu, C.C. Urinary Xist is a potential biomarker for membranous nephropathy. Biochem. Biophys. Res. Commun. 2014, 452, 415-421.
66. Kamimura, K.; Abe, H.; Suda, T.; Aoyagi, Y.; Liu, D. Liver-directed gene therapy. JSM Gastroenterol. Hepatol. 2013, 1, 1005.
67. Jiang, N.; Zhang, X.; Zheng, X.; Chen, D.; Siu, K.; Wang, H.; Ichim, T.E.; Quan, D.; McAlister, V.; Chen, G., et al. A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis. PLoS One 2012, 7, e44138.
68. Hattori, Y.; Nakamura, A.; Arai, S.; Nishigaki, M.; Ohkura, H.; Kawano, K.; Maitani, Y.; Yonemochi, E. In vivo siRNA delivery system for targeting to the liver by poly-L-glutamic acid-coated lipoplex. Results Pharm. Sci. 2014, 4, 1-7.
69. Hayashi, Y.; Yamauchi, J.; Khalil, I.A.; Kajimoto, K.; Akita, H.; Harashima, H. Cell penetrating peptide-mediated systemic siRNA delivery to the liver. Int. J. Pharm. 2011, 419, 308-313.
70. Kolli, S.; Wong, S.P.; Harbottle, R.; Johnston, B.; Thanou, M.; Miller, A.D. pH-Triggered nanoparticle mediated delivery of siRNA to liver cells in vitro and in vivo. Bioconjug. Chem. 2013, 24, 314-332.